SERUM INSTITUTE OF INDIA ON ASTRAZENECA'S WITHDRAWAL OF VAXZERVRIA: CRUCIAL TO EMPHASIZE COMMITMENT TO TRANSPARENCY AND SAFETY
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,028 GBX | +0.82% | -3.03% | +13.47% |
05-30 | Goldman Sachs Starts AstraZeneca With Buy Rating, $97 Price Target | MT |
05-30 | Goldman Sachs Kicks Off AstraZeneca Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.47% | 235B | |
+39.82% | 731B | |
+31.34% | 586B | |
-7.31% | 348B | |
+14.23% | 319B | |
+0.86% | 273B | |
-6.63% | 203B | |
+7.49% | 202B | |
+4.51% | 159B | |
-2.05% | 158B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Serum Institute Of India On Astrazeneca's Withdrawal Of Vaxzervr…